#Japan #Tokyo #AI consulting #Rozetta #Metareal PI

Metareal PI: Innovating Pharmaceutical Insights

On November 17, 2025, Rosetta, under the MetaReal Group, is set to launch a premium service for its cutting-edge AI agent, Metareal PI (Pharmaceutical Insights). This offering, priced at 50,000 JPY per month (about 380 USD), comes with exceptional capabilities of generating in-depth analytical reports on physicians' willingness to adopt and prescribe new medications.

The Power of AI in Pharmaceutical Strategy

Metareal PI stands out by analyzing medical news and physician social media posts to visualize insights regarding physicians' enthusiasm for new drug formulations. This tool empowers pharmaceutical company Medical Representatives (MRs) to accurately gauge individual physicians' interests, thus creating more effective engagement strategies. The potential to realize real-time analytics introduces a transformative approach to traditional pharmaceutical marketing and sales processes.

Identifying the Need for Change

Historically, the pharmaceutical sector relied heavily on surveys and interviews to understand doctors' willingness to adopt new medications. However, these methodologies often suffer from low response rates and transparency issues, leading to missed opportunities. Metareal PI aims to fill this gap by providing a real-time analysis of social media and news engagement, unlocking insights into physicians' genuine attitudes towards new medications.

Key Features of Metareal PI

1. Real-Time Analysis

Metareal PI continuously monitors social media and medical news, offering immediate insights into physicians' willingness to prescribe.

2. Individual Physician Assessments

Unlike traditional survey-based methods that lack personalization, Metareal PI visualizes individual doctors’ enthusiasm towards new therapies.

3. Automatic Conversion to Sales Materials

The insights generated can be seamlessly converted into ready-to-use sales documents, streamlining the communication between pharmaceutical companies and medical professionals.

This service is designed for use by MRs, marketing strategists, and departments responsible for launching new drugs, providing them with vital information to enhance their outreach efforts.

Advancing AI-Powered Consulting

In conjunction with Metareal PI, the company reinforces its commitment to specialized AI consulting through the Metareal AI series. Following the inaugural launch of Metareal DD, focusing on the financial sector, there are plans to roll out various industry-specific AI solutions aimed at addressing the distinct challenges faced across diverse fields. This initiative not only helps simplify problem-solving in various sectors but also paves the way for effective integration of AI technologies into everyday operations.

The cornerstone of our consulting services focuses on delivering fast, operationally viable AI systems, as our objective is not just to suggest solutions, but to enable rapid iteration and adaptation in real-world environments. With unparalleled speed during implementation, our methodologies are beneficial even in sectors traditionally challenged by AI integration.

Why Choose Metareal AI Consulting?

1. Specialization Over Generalization: With a proven track record of collaborating with over 6,000 companies across 2,000 industry sectors, we provide unparalleled insights and solutions tailored for niche fields.
2. AI Orchestration: By leveraging our unique AI orchestration technology, we combine multiple large language models (LLMs) to cater to specific, complex needs of various industries, ensuring precision in output.
3. Global Insights: Through our CTO, who has extensive experience in North America and Southeast Asia, we incorporate international best practices and successful strategies into our AI solutions.

Our consulting focuses on delivering the fastest path to implementing practical AI applications that genuinely meet industry needs. If your organization is considering AI adoption, we invite you to reach out for consulting support.

For further inquiries about our consulting services or to engage with our CTO for speaking opportunities, please contact: [email protected]. Additionally, on July 7, we launched a tie-up ad featuring an interview with our CTO in President Online, where you can gain more insights about our innovative strategies (Ad Link).

About MetaReal Group

MetaReal Group operates with the mission to free individuals from the constraints of time, place, and language. Positioned as the market leader in Japan's translation sector, the organization offers fully customized AI development services aimed at solving customer-specific challenges across 2,000 fields, ranging from legal, pharmaceuticals to IT and manufacturing.

For more information about us: MetaReal Group

About Rosetta Inc.

As Japan's leading AI translation company, Rosetta leverages its extensive technical expertise and robust client base to provide specialized documentation AI services needed for various industries, including pharmaceuticals, manufacturing, and finance.

For more details: Rosetta